NFL ends E.D. drug sponsorship

Share this article:
The NFL decided not to renew its sponsorship agreement with Levitra, which is co-marketed in the U.S. by Schering-Plough and GlaxoSmithKline. The league says it will not seek a replacement in the category, according to published reports. The NFL based its decision on the tone of ads for erectile dysfunction drugs. Over the past three years advertising has ranged in focus from men’s health to men’s performance and lifestyle. Ads by Levitra and others have recently been more restrained, however, not mentioning a product name but describing conditions the drug could help treat.
Share this article:

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.